We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: cardiovascular disease
MedXY News
EnglishTag

cardiovascular disease

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Comprehensive Review of Digital Nudges to Enhance Influenza Vaccination Uptake in Chronic and Cardiovascular Disease Patients
Cardiologycardiovascular diseasechronic disease

Comprehensive Review of Digital Nudges to Enhance Influenza Vaccination Uptake in Chronic and Cardiovascular Disease Patients

By MedXY|Dec 28, 2025

Electronic behavioral nudges significantly improve influenza vaccination rates among patients with chronic and cardiovascular diseases, offering scalable public health strategies.

High-Dose Influenza Vaccination Reduces Hospitalizations and Cardiovascular Events in Older Adults: Insights from the FLUNITY-HD Pooled Analysis
Cardiologycardiovascular diseasegeriatric medicine

High-Dose Influenza Vaccination Reduces Hospitalizations and Cardiovascular Events in Older Adults: Insights from the FLUNITY-HD Pooled Analysis

By MedXY|Dec 25, 2025

The FLUNITY-HD pooled analysis of over 466,000 older adults demonstrates that high-dose inactivated influenza vaccine (HD-IIV) significantly reduces hospitalizations for influenza, pneumonia, and cardiovascular causes, including a 21.3% red

Maternal Pre-existing Atherosclerotic Cardiovascular Disease: A Hidden Risk Factor for Neonatal Health and Long-term Neurodevelopment
Cardiologycardiovascular diseasematernal health

Maternal Pre-existing Atherosclerotic Cardiovascular Disease: A Hidden Risk Factor for Neonatal Health and Long-term Neurodevelopment

By MedXY|Dec 25, 2025

A nationwide cohort study demonstrates that maternal pre-existing ASCVD is independently associated with an increased risk of neonatal complications and long-term neurodevelopmental disorders, persisting regardless of adverse pregnancy outc

Beyond MACE: Semaglutide Significantly Reduces Hospitalization Burden in Patients with Obesity and Cardiovascular Disease
Cardiologycardiovascular diseasehospitalization

Beyond MACE: Semaglutide Significantly Reduces Hospitalization Burden in Patients with Obesity and Cardiovascular Disease

By MedXY|Dec 23, 2025

This exploratory analysis of the SELECT trial demonstrates that semaglutide 2.4 mg reduces total hospital admissions and total days spent in the hospital by approximately 10-11% in patients with established cardiovascular disease and obesit

Riboflavin and Blood Pressure: Evidence Remains Uncertain Despite Genetic Promise
Cardiologycardiovascular diseaseHypertension

Riboflavin and Blood Pressure: Evidence Remains Uncertain Despite Genetic Promise

By MedXY|Dec 16, 2025

Cochrane review shows uncertain effects of riboflavin on blood pressure, highlighting a need for larger and better-quality trials.

Low-Dose Colchicine Reduces Myocardial Infarction and Stroke Risk in Cardiovascular Disease Patients
Cardiologycardiovascular diseasecolchicine

Low-Dose Colchicine Reduces Myocardial Infarction and Stroke Risk in Cardiovascular Disease Patients

By MedXY|Dec 16, 2025

A large meta-analysis shows colchicine can lower MI and stroke risk without raising serious adverse events, but GI side effects remain a concern.

Planetary Health Diet and Cardiometabolic Risk Reduction in Women with Gestational Diabetes: An Evidence-Based Review
Clinical Updatescardiovascular diseaseChế độ ăn uống vì sức khỏe hành tinh

Planetary Health Diet and Cardiometabolic Risk Reduction in Women with Gestational Diabetes: An Evidence-Based Review

By MedXY|Dec 15, 2025

This review synthesizes evidence linking adherence to the Planetary Health Diet with reduced risks of myocardial infarction, type 2 diabetes, and improved weight management in women post-gestational diabetes, highlighting BMI’s mediat

EAT‑Lancet Diet and Recurrent Cardiovascular Events: Lower Stroke Risk and a Signal for Myocardial Infarction in Patients with Established CVD
Cardiologycardiovascular diseaseDietary patterns

EAT‑Lancet Diet and Recurrent Cardiovascular Events: Lower Stroke Risk and a Signal for Myocardial Infarction in Patients with Established CVD

By MedXY|Dec 3, 2025

Two cohort analyses suggest greater adherence to the EAT‑Lancet diet is linked with lower recurrent non‑fatal vascular events—notably stroke—and that education and sex modify long‑term cardioprotective benefits of this sustainable, plant‑fo

Underweight in Type 2 Diabetes Raises Cardiovascular Risk — Severe Leanness Carries Greater Risk Than Obesity
CardiologyBMIcardiovascular disease

Underweight in Type 2 Diabetes Raises Cardiovascular Risk — Severe Leanness Carries Greater Risk Than Obesity

By MedXY|Dec 2, 2025

A nationwide Korean cohort found that underweight patients with Type 2 diabetes—especially those with severe underweight—have higher cardiovascular risk than normal-weight and even some obese patients, underscoring the need to screen and ma

Hormone Therapy for Hot Flashes: Safe and Effective for Women 50–59, Harm Signals After Age 70 — New WHI Secondary Analysis Clarifies Cardiovascular Risk by Age
Cardiologycardiovascular diseaseMenopausal Hormone Therapy

Hormone Therapy for Hot Flashes: Safe and Effective for Women 50–59, Harm Signals After Age 70 — New WHI Secondary Analysis Clarifies Cardiovascular Risk by Age

By MedXY|Nov 18, 2025

A WHI secondary analysis finds that oral conjugated estrogens (with or without MPA) relieve vasomotor symptoms in women 50–59 without clear ASCVD harm, but starting HT in women ≥70 is associated with increased atherosclerotic cardiovascular

Reduced Arsenic in Drinking Water Tied to Large Drops in Cancer and Cardiovascular Mortality
Cardiologycancercardiovascular disease

Reduced Arsenic in Drinking Water Tied to Large Drops in Cancer and Cardiovascular Mortality

By MedXY|Nov 17, 2025

A prospective cohort in Bangladesh found that declines in urinary arsenic were associated with substantially lower chronic-disease mortality—including cancer and cardiovascular deaths—supporting public-health efforts to reduce arsenic expos

Do Vascular Pathways Explain How Lifestyle Affects Dementia Risk? A Critical Look at the Evidence
Cardiologycardiovascular diseasecognitive decline

Do Vascular Pathways Explain How Lifestyle Affects Dementia Risk? A Critical Look at the Evidence

By MedXY|Nov 9, 2025

A scoping review found sparse and inconsistent mediation analyses assessing cardiovascular disease as the pathway linking lifestyle factors to cognition; evidence is tentative for physical activity but urgent, better-designed studies are ne

Early Life Sugar Restriction and Its Lasting Impact on Adult Cardiovascular Health: Insights from a Natural Experiment
Cardiologycardiovascular diseasenatural experiment

Early Life Sugar Restriction and Its Lasting Impact on Adult Cardiovascular Health: Insights from a Natural Experiment

By MedXY|Oct 31, 2025

Exposure to sugar rationing during the first 1000 days after conception correlates with significantly reduced cardiovascular disease risk and improved cardiac function decades later, highlighting early nutritional influences on long-term he

Obicetrapib’s Role in Modulating Alzheimer’s Disease Biomarkers in Patients with Cardiovascular Disease: A Landmark Clinical Study
CardiologyAlzheimer's diseaseAPOE4

Obicetrapib’s Role in Modulating Alzheimer’s Disease Biomarkers in Patients with Cardiovascular Disease: A Landmark Clinical Study

By MedXY|Oct 21, 2025

Obicetrapib, a CETP inhibitor, lowers Alzheimer’s biomarkers like p-tau217 in ASCVD patients, especially ApoE4 carriers, suggesting a potential preventive strategy for high-risk individuals.

Statin Therapy in Older Adults with Chronic Kidney Disease: Primary Prevention of Cardiovascular Disease and Safety Profile in Hypercholesterolemic Patients
Cardiologycardiovascular diseasechronic kidney disease

Statin Therapy in Older Adults with Chronic Kidney Disease: Primary Prevention of Cardiovascular Disease and Safety Profile in Hypercholesterolemic Patients

By MedXY|Oct 20, 2025

This study demonstrates that statin therapy effectively reduces cardiovascular risk and all-cause mortality in older adults with chronic kidney disease and hypercholesterolemia, without increasing major adverse events, even in very elderly

Clonal Hematopoiesis in Older Adults: Implications for Cardiovascular Risk, Bleeding, and Aspirin Use
CardiologyAspirinbleeding risk

Clonal Hematopoiesis in Older Adults: Implications for Cardiovascular Risk, Bleeding, and Aspirin Use

By MedXY|Oct 15, 2025

This study reveals that clonal hematopoiesis of indeterminate potential (CHIP) in adults aged 70+ does not increase cardiovascular risk but is associated with heightened bleeding risk. Aspirin showed no additional benefits or harms for thos

Enhancing Cardiovascular Health in Kidney Transplant Recipients: Updated Evidence on Physical Activity Interventions
Cardiologycardiovascular diseaseexercise therapy

Enhancing Cardiovascular Health in Kidney Transplant Recipients: Updated Evidence on Physical Activity Interventions

By MedXY|Oct 12, 2025

An updated meta-analysis of 23 RCTs reveals that physical activity improves cardiorespiratory fitness and HDL cholesterol in adult kidney transplant recipients, suggesting important cardiovascular benefits despite current study limitations.

Early HIV Treatment and Cardiovascular Health: Insights from the START Study
Cardiologyantiretroviral therapycardiovascular disease

Early HIV Treatment and Cardiovascular Health: Insights from the START Study

By MedXY|Oct 9, 2025

Early ART initiation in HIV-positive adults with high CD4+ counts shows no overall cardiovascular benefit, but reduced CVD events in women suggest potential sex-specific effects needing further study.

Evaluating Cardiovascular-Focused Messaging to Enhance Influenza Vaccination Uptake in Diverse U.S. Populations
Cardiologycardiovascular diseaseinfluenza vaccination

Evaluating Cardiovascular-Focused Messaging to Enhance Influenza Vaccination Uptake in Diverse U.S. Populations

By MedXY|Oct 3, 2025

A large randomized trial in the U.S. found no significant improvement in influenza vaccination rates with cardiovascular-focused messaging compared to usual care, despite prior positive findings in Denmark.

Evaluating the 23-Valent Pneumococcal Polysaccharide Vaccine for Cardiovascular Event Prevention: Insights from a Landmark Randomized Trial
newsacute coronary syndromecardiovascular disease

Evaluating the 23-Valent Pneumococcal Polysaccharide Vaccine for Cardiovascular Event Prevention: Insights from a Landmark Randomized Trial

By MedXY|Oct 9, 2025

A large randomized clinical trial demonstrated that the 23-valent pneumococcal polysaccharide vaccine (PPV23) did not significantly reduce fatal or nonfatal acute coronary syndrome and ischemic stroke among middle-aged adults at increased c

Prev
3 / 4
1234
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities